Literature DB >> 15450423

A genotoxic screen: rapid analysis of cellular dose-response to a wide range of agents that either damage DNA or alter genome maintenance pathways.

Teresa Marple1, Han Li, Paul Hasty.   

Abstract

SNP analysis has come to the forefront of genomics since the mouse and human genomes have been sequenced. High throughput functional screens are necessary to evaluate these sequence databases. Described here is a genotoxic screen: a rapid method that determines the cellular dose-response to a wide range of agents that either damage DNA or alter basic cellular pathways important for maintaining genomic integrity. Importantly, a single person utilizing standard tissue culture equipment may perform these assays composed of 20 agents that attack genomic integrity or maintenance at many different levels. Thus, a small lab may perform this screen to determine the integrity of a wide range of DNA repair, chromatin metabolism, and response pathways without the limitations of investigator bias. A genotoxic screen will be useful when analyzing cells with either known genetic alterations (generated directly by the investigator or derived from individuals with known mutations) or unknown genetic alterations (cells with spontaneous mutations such as cancer-derived cells). Screening many genotoxins at one time will aid in determining the biological importance of these altered genes. Here we show the dose-response curves of mouse embryonic stem (ES) cells and HeLa cells exposed to 20 genotoxic agents. ES cells were chosen since they are amenable to genetic alteration by the investigator. HeLa cells were chosen since they were derived from cancer and are commonly used. Comparing the dose-response curves of these two cell lines show their relative sensitivity to these agents and helps define their genotoxic profile. As a part of phenomics, a large genotoxic profile database for cancer-derived cells, when integrated with other databases such as expression profiles and comparative genomic hybridization, may aid in maximizing the effectiveness of developing anti-cancer protocols.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450423     DOI: 10.1016/j.mrfmmm.2004.05.004

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  11 in total

1.  RAD51 mutants cause replication defects and chromosomal instability.

Authors:  Tae Moon Kim; Jun Ho Ko; Lingchuan Hu; Sung-A Kim; Alexander J R Bishop; Jan Vijg; Cristina Montagna; Paul Hasty
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

2.  The phenotype of FancB-mutant mouse embryonic stem cells.

Authors:  Tae Moon Kim; Jun Ho Ko; Yong Jun Choi; Lingchuan Hu; Paul Hasty
Journal:  Mutat Res       Date:  2011-03-30       Impact factor: 2.433

3.  Trex2 enables spontaneous sister chromatid exchanges without facilitating DNA double-strand break repair.

Authors:  Lavinia C Dumitrache; Lingchuan Hu; Mi Young Son; Han Li; Austin Wesevich; Ralph Scully; Jeremy Stark; Paul Hasty
Journal:  Genetics       Date:  2011-05-05       Impact factor: 4.562

4.  Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.

Authors:  Tae Moon Kim; Mi Young Son; Sherry Dodds; Lingchuan Hu; Paul Hasty
Journal:  Mutat Res       Date:  2014-06-22       Impact factor: 2.433

Review 5.  Defining a genotoxic profile with mouse embryonic stem cells.

Authors:  Tae Moon Kim; Vivienne I Rebel; Paul Hasty
Journal:  Exp Biol Med (Maywood)       Date:  2013-03

6.  Ku80-deleted cells are defective at base excision repair.

Authors:  Han Li; Teresa Marple; Paul Hasty
Journal:  Mutat Res       Date:  2013-04-06       Impact factor: 2.433

7.  Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor.

Authors:  Mariana Yaneva; Han Li; Teresa Marple; Paul Hasty
Journal:  Nucleic Acids Res       Date:  2005-09-21       Impact factor: 16.971

8.  p53 and rapamycin are additive.

Authors:  Barbara Christy; Marco Demaria; Judith Campisi; Jing Huang; Diane Jones; Sherry G Dodds; Charnae Williams; Gene Hubbard; Carolina B Livi; Xiaoli Gao; Susan Weintraub; Tyler Curiel; Z Dave Sharp; Paul Hasty
Journal:  Oncotarget       Date:  2015-06-30

9.  RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway.

Authors:  Tae Moon Kim; Mi Young Son; Sherry Dodds; Lingchuan Hu; Guangbin Luo; Paul Hasty
Journal:  Nucleic Acids Res       Date:  2014-12-17       Impact factor: 16.971

10.  Deletion of individual Ku subunits in mice causes an NHEJ-independent phenotype potentially by altering apurinic/apyrimidinic site repair.

Authors:  Yong Jun Choi; Han Li; Mi Young Son; Xiao-Hong Wang; Jamie L Fornsaglio; Robert W Sobol; Moonsook Lee; Jan Vijg; Sandra Imholz; Martijn E T Dollé; Harry van Steeg; Erwin Reiling; Paul Hasty
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.